Ebola

Protecting patients and their families from the devastating effects of Ebola is a national priority.

Stopping the spread of Ebola will require close collaboration and engagement from stakeholders across the health care system, and the biopharmaceutical industry stands ready to do its part to assist patients and their families affected by this terrible virus. Over the past several years, biopharmaceutical researchers have been working to develop vaccines and treatments to prevent infection and fight its effects, and there are at least two Ebola vaccines currently in the pipeline.

YMCA Healthy Kids Day: Promoting Childhood Wellness

04.25.14 | By

Tomorrow, April 26th, is the YMCA’s Healthy Kids Day, which promotes the important role an active and healthy lifestyle plays in the overall wellbeing of every child. Through various events during the day, the YMCA will emphasize how beneficial it is to stay active throughout the summer.

Research in North Carolina - Southeastern

Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts

Washington, D.C. (April 11, 2014) — Ian C. Read, chairman and CEO of Pfizer, Inc, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association’s annual meeting. Also elected were Kenneth C. Frazier, chairman, president and CEO of Merck & Co, Inc., as chairman-elect of the PhRMA Board of Directors, and George A. Scangos, Ph.D., CEO of Biogen Idec, as Board treasurer.

Mr. Read succeeds Robert J. Hugin, chairman and CEO of Celgene Corporation, as PhRMA’s chairman.

An ecosystem of biomedical innovation

04.09.14 | By

The guest post below by Robert Hugin originally appeard on The Hill. Hugin is the chairman and CEO of Celgene Corporation and chairman of PhRMA


America's status as the research lab for the world is no longer secure.

Research in Your Backyard: Elevating the Science of Clinical Trials

The Capitol Hosts #PhRMA14

03.31.14 | By

Another year of innovative research and development (R&D) to help patients around the world live longer, healthier lives has flown by. Beginning April 9, leaders from the biopharmaceutical industry, patient advocates, regulators, academics and others will gather in Washington, D.C. for this year’s PhRMA Annual Meeting.

Research in North Carolina - Piedmont Triad Region

Increased Access for Better Care

03.07.14 | By

Each patient is unique, which means that medicines and therapies often need to be tailored to fit individual needs to ensure the best possible care. While the research and development (R&D) pipeline holds the promise of new, innovative treatments for those suffering from a variety of diseases, it is important to explore all options to improve patient health.

The Pathway to Progress

03.06.14 | By

This post originally appeared on the Age of Personalized Medicine.

Pages

Subscribe to RSS - Innovation